Poster

PD-L1 by RNA next generation sequencing: Comparison with PD-L1 IHC 22C3 and association with survival benefit from pembrolizumab with or without chemotherapy in non-small cell lung cancer

December 1, 2020

Download

Published in: SITC's 35th Annual Meeting (2020)

Cancers & tumors Non-small cell lung cancer (NSCLC)SITC NGS: Next-gen sequencing RNA PD-L1 Oncology IHC: Immunohistochemistry